MYP_110670
Unnamed
Anticancer
Immunology
▸
Immunomodulation
▸
Immunogenic
Standard
9 amino acids
C47H74N10O16
Standard
SLVETPNYI
1035.15 Da
4.05
-1.54
-1.75
-0.1709
0.12
0.38
0.24
8.89
118.89
0.1111
1490.00
1490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
428.41
-3.41
14.0
15.0
30.0
73.0
2.0
9.0
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0102269
REVIEWED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
melanoma; HLA-A*32:01
1.809 μM
Predicted HLA-I binding
RECORD: Rec_0128105
REVIEWED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
melanoma; HLA-A*02:01
0.0388 μM
Predicted HLA-I binding
RECORD: Rec_0136092
REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
Immunogenic
melanoma; HLA-A*02:01
0.0388 μM
Clinical response
RECORD: Rec_0304577
REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
Immunogenic
melanoma; HLA-A*32:01
1.809 μM
Clinical response